Article info
PDFClinical trial
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program
- Correspondence to RAINBO Research Consortium, Leiden University Medical Center, Leiden, Netherlands; n.horeweg{at}lumc.nl
Citation
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program
Publication history
- Accepted October 31, 2022
- First published December 20, 2022.
Online issue publication
May 18, 2023
Article Versions
- Previous version (18 May 2023).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.